
|Articles|January 31, 2013
Medicare to Adjust Payment for Dialysis Drugs After Overspending Millions
Advertisement
The Medicare system is recalculating how much it will reimburse hospitals and clinics for the drugs used to treat dialysis patients after federal auditors found recently that the program could save as much as $880 million annually.
An analysis by The Washington Post in August showed that the government was overspending by hundreds of millions for just one group of those drugs.
Read the full story:
Source: The Washington Post
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
AbbVie Joins Trump Drug Pricing Effort, Pledges $100B in US R&D Investment
2
Medical Debt Emerges as Risk Factor for Housing Instability
3
OpenAI for Healthcare Aims to Streamline Clinical Workflows, Reduce Administrative Burden
4
Recurrent Thymoma With MG Effectively Treated With Methylprednisolone
5




























































